Products for Research Use Only
RegisterLogin

Anticancer agent 280

CAT: 0804-HY-179062Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-179062Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Anticancer agent 280 (Compound 65) is an anti-cancer agent targeting triple-negative breast cancer (TNBC) . Anticancer agent 280 exhibits IC50 values of Anticancer agent 280 for MDA-MB-231, MDA-MB-231/LM2-4, Jurkat, and MCF-7 of 7.1, 11.65, 6.99, and 21.51 μM respectively. Anticancer agent 280 can cause significant arrest of cells in the S phase and induce cell apoptosis. Anticancer agent 280 can be used for the study of TNBC[1].
UNSPSC
12352005
Target
Apoptosis
Related Pathways
Apoptosis
Field of Research
Cancer
Smiles
O=C(C1=CN(C2=C(C1=O)C=C(C=C2)OC3=CC=CC=C3)CC4=CC=C(C=C4)C(F)(F)F)NCC5=CC=CC=C5
Molecular Formula
C31H23F3N2O3
Molecular Weight
528.52
References & Citations
[1]Azzman N, et al. Novel 4-quinolone derivative inflicted cytotoxicity via intrinsic apoptotic pathway activation on human metastatic triple-negative breast cancer cells. Bioorg Chem. 2025 Oct;165:109033.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-174273Antibacterial agent 280
HY-155158Anticancer agent 147
HY-146040Anticancer agent 47
HY-158392Anticancer agent 219
HY-139711Anticancer agent 13
HY-170527Anticancer agent 260
HY-157931Anticancer agent 192
HY-147968Anticancer agent 74
HY-146407Anticancer agent 53
HY-115960Anticancer agent 35

Alternative Products

CatalogName
C8452-10Anticancer agent 43
T210648-01Anticancer agent 274
T210037-01Anticancer agent 239
T210028-01Anticancer agent 221
T209840-01Anticancer agent 213
T209412-01Anticancer agent 189
T209339-01Anticancer agent 196
T209334-01Anticancer agent 195
T206688-01Anticancer agent 270
T206158-01Anticancer agent 268

Popular Products